London (United Kingdom) – Stallergenes Greer plc (the “Company”) (Euronext Paris: STAGR), a biopharmaceutical company specializing in treatments for respiratory allergies, today announced the appointment of Daniel Smith as Global Head of Information Technology.
Daniel has more than 20 years of international experience in Information Technology with extensive expertise in the pharmaceutical industry. He joins Stallergenes Greer after six years at Zoetis, Inc. formerly Pfizer Pharmaceuticals International where he was responsible for driving innovation in global infrastructure business technology programs, including pharma-focused enterprise resource planning (ERP) systems, digital e-commerce, and sales force support platforms. The ERP systems included a comprehensive change management implementation covering over 27 countries supporting thousands of users in the operations and manufacturing.
Fereydoun Firouz, Chairman and Chief Executive Officer of Stallergenes Greer, said:
“I am pleased to welcome Daniel as our Global Head of Information Technology. He will play a vital role in overseeing large scale implementations and upgrades across the business, such as the continuation of the ERP rollout, while standardizing technology globally. Daniel will be responsible for developing a long-term strategic IT plan, ensuring the implementation of a best-in-class and consistent IT framework for our commercial, manufacturing and quality functions.”